This webinar has been made possible through sponsorship from Ipsen
Dr. Camillo Porta holds the Chair of Oncology at the University of Bari ‘A. Moro’ and he is also the Chief of the Division of Medical Oncology at Policlinico Consorziale in Bari, Italy, after having spent the first part of his career in his hometown of Pavia, also in Italy. He is a member of the ESMO scientific committee for the GU cancers track, as well of the ESMO kidney cancer guidelines committee, his main research field of interest being the development of novel agents for the treatment of kidney cancer. He has published more than 360 peer-reviewed papers on international journals, and has a cumulative H-index of 54. .
Dr. Christian Kollmannsberger is staff Medical Oncologist at the British Columbia Cancer Agency (BCCA) Vancouver Cancer Centre and Clinical Professor at the University of British Columbia. He graduated from the Technical University in Munich, Germany and received his clinical training in internal medicine, haematology and medical oncology, mainly at University of Tuebingen, Germany. Dr. Kollmannsberger's research is focused on genito-urinary malignancies with a special interest in testicular and renal cell cancer. Nationally and internationally, he has contributed to numerous trials in the field of renal cell carcinoma and testicular cancer. He has repeatedly served as faculty for the Annual meeting of the American Society of Clinical Oncology (ASCO), the ASCO Genitourinary Cancers Symposium, and the Annual Meeting of the European Society of Medical Oncology (ESMO). Currently, Dr. Kollmannsberger serves as chair of the BC Cancer Agency Genitourinary Cancers Systemic Therapy Group and the chair for the Genitourinary Clinical Trials Unit at BC Cancer Vancouver Centre.
For more information, please send requests to Jocelyn Healey: email@example.com.